The Food and Drug Administration on Monday approved a shot to protect infants and vulnerable toddlers against respiratory syncytial virus, or R.S.V., offering one of the first protections for an illness that fills children’s hospitals year after year.The monoclonal antibody shot is expected to be available at the start of the fall R.S.V. season. The…
